跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,036 条关于
“SCAC”
全部
2,036
临床试验
1,899
药物
24
机构
0
资讯
113
去年
Retifanlimab Plus Chemotherapy Shows Promise in Advanced Squamous Cell Anal Carcinoma
2年前
Retifanlimab Plus Chemotherapy Extends Progression-Free Survival in Advanced Squamous Cell Anal Carcinoma
2年前
Incyte's Zynyz Shows Promise in Frontline Anal Cancer Treatment
9个月前
Japan Approves Zynyz for First-Line Treatment of Advanced Anal Cancer
去年
Bicara's Ficerafusp Alfa Shows Promise in Advanced Anal Cancer Trial
去年
Bicara's Ficerafusp Alfa Shows Promise in EGFR+ Anal Cancer Trial When Combined with Keytruda
4年前
Retifanlimab Shows Durable Activity in Advanced Anal Canal Cancer
2年前
Retifanlimab Plus Chemotherapy Improves Outcomes in Advanced Anal Cancer
去年
Immunotherapy Combinations Transform Advanced Squamous Cell Anal Cancer Treatment Landscape
2年前
Retifanlimab Plus Chemotherapy Improves PFS in Advanced Anal Cancer
第 1 页,共 12 页
上一页
下一页